|

Comparison of Intensive Versus Standard Care & Education for Dyslipidemia in Hypertension and Diabetes Patients

RECRUITINGN/ASponsored by Saint Vincent's Hospital, Korea
Actively Recruiting
PhaseN/A
SponsorSaint Vincent's Hospital, Korea
Started2025-04-01
Est. completion2025-12-31
Eligibility
Age30 Years – 80 Years
Healthy vol.Accepted

Summary

The prevalence of dyslipidemia is high among patients with hypertension and diabetes mellitus, which increases the risk of cardiovascular disease. However, many patients lack awareness and adherence to treatment and lifestyle modifications. Therefore, a more structured and intensive approach to management and education is required. This study aims to implement intensive dyslipidemia management and education for patients registered at the Hanam City Hypertension and Diabetes Education Center and evaluate changes in blood lipid levels accordingly. Additionally, the study will analyze the impact of intensive education on patients' quality of life, health behaviors, and treatment adherence, ultimately contributing to the development of effective management strategies.

Eligibility

Age: 30 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patients registered in the Hanam City Hypertension and Diabetes Program
* Adults aged 30 to 80 years
* Individuals who have provided written informed consent to participate in the study

Exclusion Criteria:

* Chronic kidney disease stage 4 or higher (eGFR \<30 mL/min/1.73m²)
* Patients with liver cirrhosis or severe liver disease
* Patients with a history of acute coronary syndrome within the past 6 months
* Pregnant or breastfeeding women • Individuals with psychiatric disorders that may affect study participation

Conditions5

DiabetesDiabetes MellitusDyslipidemiaHypertensionPrimary Prevention

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.